日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Analysis of diagnosis delay among migrant pulmonary tuberculosis patients in Guangzhou from 2014 to 2022

2014年至2022年广州市流动人口肺结核患者诊断延误情况分析

期刊:Frontiers in Public Health
影响因子:3.4
doi:10.3389/fpubh.2025.1399688
Feng, Yajuan; Lai, Keng; Yang, Jieying; Lei, Yu; Wu, Guifeng; Du, Yuhua; He, Weiyun
微生物学
肺结核
发表日期：2025
文献求助 收藏

Adverse event profile of crizotinib in real-world from the FAERS database: a 12-year pharmacovigilance study

来自FAERS数据库的克唑替尼真实世界不良事件概况：一项为期12年的药物警戒研究

期刊:
影响因子:
doi:10.1186/s40360-025-00859-6
Zhang, Huan; Song, Yunrui; Xia, Fantong; Liu, Yunchang; Zhang, Lu; Yang, Jieying; Tu, Honglei; Long, Bin; Sui, Jiangdong; Wang, Ying
发表日期：2025
文献求助 收藏

Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles

通过二氧化铈纳米粒子靶向降解突变型p53蛋白实现胰腺癌的精准治疗

期刊:Journal of Nanobiotechnology
影响因子:10.6
doi:10.1186/s12951-023-01867-6
Hao Zhang, Wang Zhang, Bochuan Hu, Xiaohua Qin, Tianxiang Yi, Yayi Ye, Xiaowan Huang, Yang Song, Zhenyu Yang, Jieying Qian, Yunjiao Zhang
代谢
肿瘤
胰腺癌
WB
P53
发表日期：2023
文献求助 收藏

BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma.

BMP9 诱导的血管正常化可提高针对乙型肝炎病毒相关肝细胞癌的免疫疗法的疗效

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.1247
Han Yulong, Pan Qiuzhong, Guo Zhixing, Du Yufei, Zhang Yaojun, Liu Yingying, Zhao Jingjing, Xu Jinfeng, Yang Jieying, Ouyang Dijun, Tang Yan, Wang Qijing, Li Yongqiang, He Jia, Yang Mengjuan, Chen Hao, Yang Chaopin, Yang Xinyi, You Jinqi, Chen Yuanyuan, Ren Minghao, Zhu Yao, Xia Jianchuan, Xiang Tong
细胞生物学
发表日期：2023
文献求助 收藏

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype

CircITGB6通过将肿瘤相关巨噬细胞极化重置为M2表型，促进卵巢癌对顺铂的耐药性。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-004029
Li, Han; Luo, Fan; Jiang, Xingyu; Zhang, Weijing; Xiang, Tong; Pan, Qiuzhong; Cai, Liming; Zhao, Jingjing; Weng, Desheng; Li, Yue; Dai, Yuhu; Sun, Fengze; Yang, Chaopin; Huang, Yue; Yang, Jieying; Tang, Yan; Han, Yulong; He, Mian; Zhang, Yanna; Song, Libing; Xia, Jian-Chuan
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
卵巢癌
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma

CMTM6通过阻止肝细胞癌中p21的泛素化来抑制肿瘤生长并逆转化疗耐药性。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-022-04676-1
Huang, Yue; Zhu, Yingqin; Yang, Jieying; Pan, Qiuzhong; Zhao, Jingjing; Song, Mengjia; Yang, Chaopin; Han, Yulong; Tang, Yan; Wang, Qijing; He, Jia; Li, Yongqiang; He, Junyi; Chen, Hao; Weng, Desheng; Xiang, Tong; Xia, Jian Chuan
肿瘤
表观遗传
肿瘤免疫
泛素化
CMTM6
细胞生物学
发表日期：2022
文献求助 收藏

AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma

NRF2/MAFG复合物调控的AKR1C3通过稳定PARP1促进肝细胞癌增殖

期刊:Oncogene
影响因子:6.9
doi:10.1038/s41388-022-02379-7
Di Pan #, Wanwan Yang #, Yao Zeng #, Hongkun Qin, Yuting Xu, Yanping Gui, Xiangshan Fan, Geng Tian, Yujia Wu, Haopeng Sun, Yuting Ye, Shihe Yang, Jieying Zhou, Qinglong Guo, Li Zhao
肿瘤
肝癌
其它细胞
发表日期：2022
文献求助 收藏

Identification of polyunsaturated fatty acids related key modules and genes in metabolic dysfunction-associated fatty liver disease using WGCNA analysis

使用 WGCNA 分析鉴定代谢功能障碍相关脂肪肝疾病中多不饱和脂肪酸相关的关键模块和基因

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2022.951224
Cheng Xiao, Siliang Chen, Chunru Yang, Jieying Liu, Miao Yu
代谢
脂肪肝
发表日期：2022
文献求助 收藏

Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin

抑制 DTYMK 可显著抑制 HCC 的生长并增加对奥沙利铂的敏感性

期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-021-04375-3
Fengze Sun #, Yuanyuan Liu #, Tingting Gong #, Qiuzhong Pan, Tong Xiang, Jingjing Zhao, Yan Tang, Hao Chen, Yulong Han, Mengjia Song, Yue Huang, Han Li, Yuanyuan Chen, Chaopin Yang, Jieying Yang, Qijing Wang, Yongqiang Li, Jia He, Desheng Weng, Ruiqing Peng, Jianchuan Xia
信号转导
WB
发表日期：2021
文献求助 收藏

The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study.

阿昔替尼联合帕博利珠单抗激活的自体DC-CIK细胞免疫疗法治疗晚期肾细胞癌患者的疗效和安全性：一项2期研究

期刊:Clinical & Translational Immunology
影响因子:3.8
doi:10.1002/cti2.1257
Song Meng-Jia, Pan Qiu-Zhong, Ding Ya, Zeng Jianxiong, Dong Pei, Zhao Jing-Jing, Tang Yan, Li Jingjing, Zhang Zhiling, He Junyi, Yang Jieying, Huang Yue, Peng Ruiqing, Wang Qi-Jing, Gu Jia-Mei, He Jia, Li Yong-Qiang, Chen Shi-Ping, Huang Rongxing, Zhou Zi-Qi, Yang Chaopin, Han Yulong, Chen Hao, Liu Heping, Xia Shangzhou, Wan Yang, Weng De-Sheng, Xia Liming, Zhou Fang-Jian, Xia Jian-Chuan
细胞生物学
肿瘤免疫
发表日期：2021
文献求助 收藏